GlassScriptPhysician profile
Christopher Alan Healy
NPI 1033352877
$208,646.34
in general payments reported to CMS, 2019-2025
37 companies · $100K in 2025
The $100K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,645 · 2020: $3,994 · 2021: $1,605 · 2022: $26K · 2023: $31K · 2024: $42K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56K · Travel and Lodging: $32K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,005.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,710.00 |
| Travel and Lodging | $32,308.14 |
| Food and Beverage | $12,925.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $146,297.98 | 2019-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided, Igt Devices Systems Undivided |
| Boston Scientific Corporation | $36,587.85 | 2019-2025 | General - Therapies, General - Ep, Rhythmia Mapping System |
| Medtronic, INC. | $10,876.47 | 2021-2025 | Affera Mapping System, Micra, Pulseselect |
| Abbott Laboratories | $6,188.58 | 2019-2025 | Aveir, Ensite, Ensite Precision |
| Biotronik INC. | $5,657.43 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Novartis Pharmaceuticals Corporation | $279.54 | 2019-2025 | |
| Pfizer INC. | $247.01 | 2019-2025 | |
| Inari Medical, INC. | $231.11 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $211.16 | 2022-2025 | Brilinta, Farxiga |
| Novo Nordisk INC | $197.61 | 2019-2025 | Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.19 | 2024-2025 | Lifevest |
| Medtronic Vascular, INC. | $168.49 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.43 | 2022-2025 | |
| Amgen INC. | $146.21 | 2020-2025 | Repatha, Repatha |
| Cardiofocus, INC. | $145.16 | 2019 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.